Nanodimension 13F annual report
Nanodimension is an investment fund managing more than $24.7 million ran by Peter Liddiard. There are currently 4 companies in Mr. Liddiard’s portfolio. The largest investments include Twist Bioscience Corp and Selecta Biosciences Inc, together worth $17.1 million.
$24.7 million Assets Under Management (AUM)
As of 2nd November 2022, Nanodimension’s top holding is 307,740 shares of Twist Bioscience Corp currently worth over $10.8 million and making up 44.0% of the portfolio value.
Relative to the number of outstanding shares of Twist Bioscience Corp, Nanodimension owns more than approximately 0.1% of the company.
In addition, the fund holds 3,787,515 shares of Selecta Biosciences Inc worth $6.21 million, whose value grew 99.5% in the past six months.
The third-largest holding is Icosavax Inc worth $4.3 million and the next is SQZ Biotechnologies Co worth $3.3 million, with 1,445,221 shares owned.
Currently, Nanodimension's portfolio is worth at least $24.7 million. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
Careers at Nanodimension
The Nanodimension office and employees reside in Woodside, California. According to the last 13-F report filed with the SEC, Peter Liddiard serves as the Chief Financial Officer at Nanodimension.
Recent trades
Peter Liddiard disclosed a decreased stake in Selecta Biosciences Inc by approximately 0.1%.
This leaves the value of the investment at $6.21 million and 3,787,515 shares.
One of the smallest hedge funds
The two most similar investment funds to Nanodimension are Kokino and Tiedemann Wealth Management. They manage $24.7 million and $24.8 million respectively.
Peter Liddiard investment strategy
Nanodimension’s portfolio is diversified across 2 sectors.
Currently, their heaviest sector is Health Care — making up 82.5% of
the total portfolio value.
The fund focuses on investments in the United States as
75.0% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are small-cap stocks.
Stocks with a size of more than $100 million in market cap make up
25% of the total holdings value.
On the other hand, large-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $590 million.
The complete list of Nanodimension trades based on 13F SEC filings
These positions were updated on November 9th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
Security | Shares Owned | Value | Allocation |
---|---|---|---|
Twist Bioscience Corp |
No change
307,740
|
$10,845,000 | 43.99% |
Selecta Biosciences Inc |
5.37%
3,787,515
|
$6,212,000 | 25.20% |
Icosavax Inc |
21.56%
1,361,658
|
$4,303,000 | 17.45% |
SQZ Biotechnologies Co |
No change
1,445,221
|
$3,295,000 | 13.36% |
No transactions found | |||
Showing first 500 out of 4 holdings |
Hedge funds similar to Nanodimension
- Ulys, L.L.C
- Fsi Group
- Vcu Investment Management Co
- Schooner Capital Corp
- Frontfour Capital
- Tiedemann Wealth Management
- Kokino
- Drill Craig A
- Wheatland Advisors Inc
- Black Horse Capital Management
- Craft Ventures Gp Ii
- Provenire Capital
- Suntx Capital Management
- Seven Grand Managers